Masahiro Takeyama

The measurement of low levels of factor VIII or factor IX in hemophilia A and hemophilia B plasma by clot waveform analysis and thrombin generation assay

Tomoko Matsumoto, Midori Shima, Masahiro Takeyama et al. · Journal of Thrombosis and Haemostasis · 2006 · 93 citations

Clot Waveform Analysis, Thrombosis, Laboratory Hematology +12

Global coagulation function assessed by rotational thromboelastometry predicts coagulation-steady state in individual hemophilia A patients receiving emicizumab prophylaxis

Koji Yada, Keiji Nogami, Kenichi Ogiwara et al. · International Journal of Hematology · 2019 · 66 citations

Thrombosis, Global Coagulation Function, Venous Thrombosis +8

The Factor VIIIa C2 Domain (Residues 2228–2240) Interacts with the Factor IXa Gla Domain in the Factor Xase Complex

Tetsuhiro Soeda, Keiji Nogami, Katsumi Nishiya et al. · Journal of Biological Chemistry · 2008 · 54 citations · Full text

Residues 2228–2240, Molecular Immunology, Protein Function +15

Assessing the clinical severity of type 1 von Willebrand disease patients with a microchip flow‐chamber system

Keiji Nogami, Kenichi Ogiwara, Koji Yada et al. · Journal of Thrombosis and Haemostasis · 2016 · 30 citations · Full text

Type 1, Hematology, Diagnosis +4

An anti‐factor IXa/factor X bispecific antibody, emicizumab, improves ex vivo coagulant potentials in plasma from patients with acquired hemophilia A

Masahiro Takeyama, Keiji Nogami, Tomoko Matsumoto et al. · Journal of Thrombosis and Haemostasis · 2020 · 28 citations

Inflammation, Immunohematology, Thrombosis +9